The Long Run with Luke Timmerman
A podcast by Timmerman Report

173 Episodes
-
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Published: 6/7/2022 -
Ep114: Chris Gibson on Industrializing Drug Discovery
Published: 5/23/2022 -
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
Published: 5/9/2022 -
Ep112: Bernat Olle on Microbiome Therapeutics
Published: 4/18/2022 -
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
Published: 3/14/2022 -
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
Published: 3/1/2022 -
Ep109: Derrell Porter on Cell Therapy Commercialization
Published: 2/15/2022 -
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
Published: 1/31/2022 -
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building
Published: 1/11/2022 -
Ep106: Vineeta Agarwala on Health Data & VC Investing
Published: 12/20/2021 -
Ep105: Nello Mainolfi on Targeted Protein Degraders
Published: 12/6/2021 -
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
Published: 12/1/2021 -
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
Published: 11/23/2021 -
Ep102: David Baltimore Reflects on a Life in Science
Published: 11/8/2021 -
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs
Published: 10/26/2021 -
Ep100: Christian Henry on Long Read DNA Sequencing
Published: 10/13/2021 -
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations
Published: 9/27/2021 -
Ep98: Mara Aspinall on Diagnostics and COVID-19
Published: 9/13/2021 -
Ep97: John Evans on Base Edited Therapeutics
Published: 9/7/2021 -
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Published: 8/9/2021
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.